Literature DB >> 11087215

Persistent but reversible coronary microvascular dysfunction after bypass grafting.

N Spyrou1, M A Khan, S D Rosen, R Foale, D W Davies, F Sogliani, R D Stanbridge, P G Camici.   

Abstract

The effect of coronary artery bypass grafting (CABG) on absolute myocardial blood flow (MBF) has not been investigated previously. MBF (ml. min(-1). g(-1)) was measured at rest and during hyperemia (0.56 mg/kg iv dipyridamole) using H(2)(15)O and positron emission tomography in eight patients with three-vessel disease before surgery and 1 and 6 mo after full revascularization. Baseline MBF was 0.87 +/- 0.12 preoperatively and 1.04 +/- 0.14 and 0.95 +/- 0.13 at 1 and 6 mo after CABG, respectively (P < 0.05, 6 mo vs. preoperatively). Hyperemic MBF was 1.36 +/- 0.28 preoperatively and increased to 1.98 +/- 0.50 and 2.45 +/- 0.64 at 1 and 6 mo after CABG, respectively (P < 0.01, 6 mo vs. preoperatively). Coronary vasodilator reserve (hyperemic/baseline MBF) increased from 1.59 +/- 0.40 preoperatively to 1.93 +/- 0.13 and 2.57 +/- 0.49 at 1 and 6 mo, respectively (P < 0.05, 6 mo vs. preoperatively). Minimal (dipyridamole) coronary resistance (mmHg. min. g(-1). ml(-1)) fell progressively from 59.37 +/- 14.56 before surgery to a nadir of 35. 76 +/- 10.12 at 6 mo after CABG (P < 0.01 vs. preoperatively). The results of the present study confirm that CABG improves coronary vasodilator reserve progressively as a result of reduction in minimal coronary resistance. These data suggest persistent microvascular dysfunction that recovers slowly after surgery.

Entities:  

Mesh:

Year:  2000        PMID: 11087215     DOI: 10.1152/ajpheart.2000.279.6.H2634

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

Review 1.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

2.  Myocardial viability, coronary flow reserve, and in-hospital predictors of late recovery of contractility following successful primary stenting for acute myocardial infarction.

Authors:  F Beygui; C Le Feuvre; G Helft; C Maunoury; J P Metzger
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

3.  EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging.

Authors:  Roberto Sciagrà; Mark Lubberink; Fabien Hyafil; Antti Saraste; Riemer H J A Slart; Denis Agostini; Carmela Nappi; Panagiotis Georgoulias; Jan Bucerius; Christoph Rischpler; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-02       Impact factor: 9.236

Review 4.  Non-invasive Ischaemia Testing in Patients With Prior Coronary Artery Bypass Graft Surgery: Technical Challenges, Limitations, and Future Directions.

Authors:  Andreas Seraphim; Kristopher D Knott; Joao B Augusto; Katia Menacho; Sara Tyebally; Benjamin Dowsing; Sanjeev Bhattacharyya; Leon J Menezes; Daniel A Jones; Rakesh Uppal; James C Moon; Charlotte Manisty
Journal:  Front Cardiovasc Med       Date:  2021-12-23

5.  Off-pump coronary artery bypass grafting using a bilateral internal mammary artery Y graft.

Authors:  Cheng-Xiong Gu; Jun-Feng Yang; Hong-Chao Zhang; Hua Wei; Ling-Ke Li
Journal:  J Geriatr Cardiol       Date:  2012-09       Impact factor: 3.327

6.  Total Arterial Off-pump Coronary Revascularization with a Bilateral Internal Mammary Artery Y Graft (208 cases).

Authors:  Jun-Feng Yang; Hong-Chao Zhang; Cheng-Xiong Gu; Hua Wei
Journal:  J Surg Tech Case Rep       Date:  2012-01

7.  Coronary flow velocity reserve by echocardiography: feasibility, reproducibility and agreement with PET in overweight and obese patients with stable and revascularized coronary artery disease.

Authors:  Rasmus Huan Olsen; Lene Rørholm Pedersen; Martin Snoer; Thomas Emil Christensen; Adam Ali Ghotbi; Philip Hasbak; Andreas Kjaer; Steen B Haugaard; Eva Prescott
Journal:  Cardiovasc Ultrasound       Date:  2016-06-07       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.